Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement Claudio Lucetti, Gianna Gambaccini, Paolo Del Dotto, Roberto Ceravolo, Chiara Logi, Giuseppe Rossi, Luigi Murri, Ubaldo Bonuccelli Parkinsonism & Related Disorders Volume 12, Issue 5, Pages 279-283 (June 2006) DOI: 10.1016/j.parkreldis.2005.12.005 Copyright © 2006 Terms and Conditions
Fig. 1 Kaplan–Meier survival curves showed a different pattern of occurrence of levodopa intake in AI (○) and non-AI (□) patients (p<.01). At the end of the 5-year follow-up, 8 (45%) patients in AI group and 27 (82%) in non-AI group were on monotherapy with dopamine agonist. Parkinsonism & Related Disorders 2006 12, 279-283DOI: (10.1016/j.parkreldis.2005.12.005) Copyright © 2006 Terms and Conditions